Showing results (191-200 of 281) with videos related to
Sort By:
Pageof 29
Statistics in Medicine|September 11, 2012
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?Michael Proschan, Charles E Ford, Jeffrey A Cutler, et al.JAMA|April 7, 2005
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinoprilJackson T Wright, J Kay Dunn, Jeffrey A Cutler, et al.Clinical Trials (London, England)|July 10, 2009
Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination ProjectL Kay Bartholomew, William C Cushman, Jeffrey A Cutler, et al.The New England Journal of Medicine|June 10, 2008
Effects of intensive glucose lowering in type 2 diabetes, Hertzel C Gerstein, Michael E Miller, et al.Circulation|May 18, 2017
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)Elsayed Z Soliman, Walter T Ambrosius, William C Cushman, et al.Journal of the American College of Cardiology|January 31, 2017
ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesWiley V Chan, Thomas A Pearson, Glen C Bennett, et al.The New England Journal of Medicine|March 4, 2011
Long-term effects of intensive glucose lowering on cardiovascular outcomes, Hertzel C Gerstein, Michael E Miller, et al.Journal of the American Society of Hypertension : JASH|September 27, 2016
Orthostatic changes in systolic blood pressure among SPRINT participants at baselineRaymond R Townsend, Tara I Chang, Debbie L Cohen, et al.Journal of General Internal Medicine|August 9, 2022
Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention TrialDae Hyun Kim, Curtis Tatsuoka, Zhengyi Chen, et al.Lancet (London, England)|June 14, 2019
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trialHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.Pageof 29